Health-Related Quality of Life in Obese Children and Adolescents

  • M. de Beer
  • R. J. B. J. Gemke
Reference work entry


Prosperity is accompanied by a rapidly increasing prevalence of overweight and obesity, especially among children and adolescents. This has major implications for the occurrence of cardiovascular (e.g., hypertension, stroke) and metabolic (e.g., insulin resistance and dyslipidemia) diseases in adulthood, not only regarding their prevalence but also as they increasingly occur at a relatively younger (adult of even adolescent) age. Obesity is not only responsible for these slowly and sub clinically presenting somatic conditions but is also closely associated with development of adverse psychological and social conditions. This burden of obesity has both short and long term effects while children and adolescents are particularly vulnerable for adverse psychosocial consequences. Health related quality of life is a concept that enables to assess overall well-being in large groups of healthy subjects and those with a (acute or chronic) condition. In this chapter the concepts of measuring health related quality of life in children and adolescents will be reviewed followed by the introduction and discussion of generic and condition (obesity) specific measures for assessment of health related quality of life. Subsequently the relation of obesity with (impairment of) health related quality of life will be reviewed by a number of relevant studies. Rather than to provide an exhaustive review we sought to provide a representative sample of studies that (1) were methodologically sound; (2) comprised an adequate sample size; (3) comprised individuals across a broad range of relative body weight (body mass index,  BMI [kg/m2];) and (4) used generally well-validated measures of HRQL. Thereafter the effects of interventions on health related quality of life in obese children and adolescents will be discussed and finally a perspective for future research on this topic is proposed.


Obese Child Obese Adolescent Child Health Questionnaire Obese Youth Normal Weight Control 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:


body mass index


child health questionnaire


child health questionnaire child form


child health questionnaire parent form


health related quality of life


health utilities index


impact of weight on quality of life


kinderlebensqualität fragenbogen


municipal health service


pediatric quality of life inventory


quality of life


short form 36


standard gamble


TNO-AZL children quality of life


TNO-AZL pre-school children quality of life


time trade-off


visual analogue scales


  1. Apajasalo M, Rautonen J, Homberg C. (1996a). Qual Life Res. 5: 532–538.PubMedCrossRefGoogle Scholar
  2. Apajasalo M, Sintonen H, Holmberg C, et al. (1996b). Qual Life Res. 5: 205–211.PubMedCrossRefGoogle Scholar
  3. Bennett K, Torrance GW. (1996). Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. Spilker B (ed.) Quality of Life and Pharmacoeconomics in Clinical Trials. Lippincott-Raven, Philadelphia, PA, pp. 253–265.Google Scholar
  4. Boyle MH, Furlong W, Feeny D, et al. (1995). Qual Life Res. 4: 249–257.PubMedCrossRefGoogle Scholar
  5. De Beer M, Hofsteenge GH, Koot HM, HiraSing RA, Delemarre-van de Waal HA, Gemke RJBJ. (2007). Acta Paediatr. 96: 710–714.PubMedCrossRefGoogle Scholar
  6. Doyle AC, Le Grange D, Goldschmidt A, Wilfley DE. (2007). Obesity (Silver Spring). 15: 145–154.CrossRefGoogle Scholar
  7. Eiser C, Jenney MEM. (1996). BR J Cancer. 73: 1313–1316.PubMedCrossRefGoogle Scholar
  8. Eiser C, Kopel SJ. (1997). Children’s perception of health ad illness. In: Petrie KJ, Weinman JA, (ed.) Perceptions of Health and Illness: Current Research and Applications. Harwood Academic Publishers, Singapore.Google Scholar
  9. Eiser C, Morse R. (2001). Arch Dis Child. 84: 205–211.PubMedCrossRefGoogle Scholar
  10. Fallon EM, Tanofsky-Kraff M, Norman AC, McDuffie JR, Taylor ED, Cohen ML et al. (2005). J Pediatr. 147: 443–450.PubMedCrossRefGoogle Scholar
  11. Fekkes M, Theunissen NC, Brugman E, Veen S, Verrips EG, Koopman HM, Vogels T, Wit JM, ad Verloove-Vanhorick SP. (2000). Qual Life Res. 9: 961–972.PubMedCrossRefGoogle Scholar
  12. Fontaine KR, Barofsky I. (2001). Obes Rev. 2: 173–182.PubMedCrossRefGoogle Scholar
  13. García-Morales LM, Berber A, Macias-Lara CC, Lucio-Ortiz C, Del-Rio-Navarro BE, Dorantes-Alvárez LM. (2006). Clin Ther. 28: 770–782.PubMedCrossRefGoogle Scholar
  14. Guyatt GH, Feeny DH, Patrick DL. (1993). Ann Int Med. 118: 622–629.PubMedGoogle Scholar
  15. Guyatt GH, Ferras CE, Halyard MY, Revicki DA, Symonds TL, Varricchio CG et al. (2007). Mayo Clin Proc. 82: 1229–1239.PubMedCrossRefGoogle Scholar
  16. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. (2004). JAMA. 291: 2847–2850.PubMedCrossRefGoogle Scholar
  17. Inge TH, Xanthakos SA, Zeller MH. (2007). Int J Obes. 31: 1–14.CrossRefGoogle Scholar
  18. Ingerski LM, Janicke DM, Silverstein JH. (2007). J Pediatr Psychol. 32: 869–874.PubMedCrossRefGoogle Scholar
  19. Janicke DM, Marciel KK, Ingerski LM, Novoa W, Lowry KW, Sallinen BJ et al. (2007). Obesity (Silver Spring). 15: 1799–1807.CrossRefGoogle Scholar
  20. Jelalian E, Mehlenbeck R. (2002). J Clin Psychol Med Settings. 9: 15–23.CrossRefGoogle Scholar
  21. Jelalian E, Mehlenbeck R, Lloyd-Richardson EE, Birmaher V, Wing RR. (2006). Int J Obes (Lond). 30: 31–39.CrossRefGoogle Scholar
  22. Kolotkin RL, Crosby RD. (2002). Qual Life Res. 11: 157–171.PubMedCrossRefGoogle Scholar
  23. Kolotkin RL, Head S, Brookhart A. (1997). Obes Res. 5: 434–441.PubMedGoogle Scholar
  24. Kolotkin RL, Zeller MH, Modi AC, Samsa GP, Quinlan NP, Yanovski JA et al. (2006). Obesity (Silver Spring).14: 448–457.CrossRefGoogle Scholar
  25. Kortt MA, Clarke PM. (2005). Qual Life Res. 14: 2177–2185.PubMedCrossRefGoogle Scholar
  26. Landgraf JMJM, Abetz L, Ware JE. (1996). The CHQ User’s Manual. The Health Institute, New England Medical Center, Boston, MA.Google Scholar
  27. Lee AJ, Morgan CL, Morrissey M, Wittrup-Jensen KU, Kenedy-Martin T, Currie CJ. (2005). Diabet Med. 22: 1482–1486.PubMedCrossRefGoogle Scholar
  28. Matza LS, Swensen AR, Flood EM, Secnik K, Leidy NK. (2004). Value Health. 7: 79–92.PubMedCrossRefGoogle Scholar
  29. Pinhas-Hamiel O, Singer S, Pilpel Fradkin A, Moda D, Reihman B. (2006). Int J Obes (Lond). 30: 267–272.CrossRefGoogle Scholar
  30. Ravens Sieberer U, Bullinger M. (1998). Qual Life Res. 7: 399–407.PubMedCrossRefGoogle Scholar
  31. Ravens-Sieberer U, Redegeld M, Bullinger M. (2001). Int J Obes Relat Metab Disor. 25 (Suppl 1): S63–S65.CrossRefGoogle Scholar
  32. Schipper H, Clich JJ, Olweny CL. (1996). Quality of life studies: definitions and conceptual issues. In: Spilker B (ed.) Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd ed. Lippincott-Raven, Philadelphia, PA, pp. 11–23.Google Scholar
  33. Schwimmer JB, Burwinkle TM, Varni JW. (2003). JAMA. 289: 1813–1819.PubMedCrossRefGoogle Scholar
  34. Spencer NJ, Coe C. (1996). Child Care Health Dev. 22: 367–379.PubMedCrossRefGoogle Scholar
  35. Starfield B, Bergner M, Ensminger M, et al. (1993). Pediatrics. 91: 430–435.PubMedGoogle Scholar
  36. Stei RE, Jessop DJ. (1990). Med Care. 28: 1041–1055.CrossRefGoogle Scholar
  37. Stern M, Mazzeo SE, Gerke CK, Porter JS, Bean MK, Laver JH. (2007). J Pediatr Psychol. 32: 90–94.PubMedCrossRefGoogle Scholar
  38. Swallen KC, Reither EN, Haas SA, Meier AM. (2005). Pediatrics. 115: 340–347.PubMedCrossRefGoogle Scholar
  39. Ten S, Maclaren N. (2004). J Clin Endocrinol Metab. 89: 2526–2539.PubMedCrossRefGoogle Scholar
  40. Van den Hurk K, van Dommelen P, van Buuren S, Verkerk PH, Hirasing RA. (2007). Arch Dis Child. 92: 992–995.PubMedCrossRefGoogle Scholar
  41. Varni JW, Seid M, Rode CA. (1999). Med Care. 37: 126–139.PubMedCrossRefGoogle Scholar
  42. Vogels T, Verrips GH, Verloove-Vanhorick SP, et al. (1998). Qual Life Res. 7: 457–465.PubMedCrossRefGoogle Scholar
  43. Wadden TA, Stunkard AJ, Rich L, Rubin CJ, Sweidel G,McKinney S. (1990). Pediatrics. 85: 345–352.PubMedGoogle Scholar
  44. Wake M, Salmon L, Waters E, Wright M, Hesketh K. (2002). Int J Obes Relat Metab Disord. 26: 717–724.PubMedCrossRefGoogle Scholar
  45. Walker Lowry K, Sallinen BJ, Janicke DM. (2007). J Pediatr Psychol. 32: 1179–1195.CrossRefGoogle Scholar
  46. Ware JEJ. (1996). The SF-36 health survey. In: Spilker B (ed.) Quality of Life ad Pharmacoeconomics in Clinical Trials. Lippincott-Raven, Philadelphia PA, pp. 337–345.Google Scholar
  47. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW et al. (2004). N Engl J Med. 350: 2362–2374.PubMedCrossRefGoogle Scholar
  48. Williams J, Wake M, Hesketh K, Maher E, Waters E. (2005). JAMA. 293: 70–76.PubMedCrossRefGoogle Scholar
  49. Zeller MH, Modi AC. (2006). Obesity (Silver Spring). 14: 122–130.CrossRefGoogle Scholar
  50. Zeller MH, Roehrig HR, Modi AC, Daniels SR, Inge TH. (2006). Pediatrics. 117: 1155–1561.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • M. de Beer
  • R. J. B. J. Gemke

There are no affiliations available

Personalised recommendations